Night Shift Work Now Found to Have No Effect on Breast Cancer Risk


Despite previous thought, working night shifts does not increase the risk of breast cancer.

In its 2007 review, the World Health Organization’s International Agency for Research on Cancer categorized shift work that involves disruption of the circadian rhythm as a probable carcinogen. Although this conclusion was based on animal studies, the messaging to the public was that working nights caused or contributed to the development of breast cancer.

To examine whether or not night shift work could increase the risk of developing breast cancer, researchers at Oxford University in the United Kingdom (UK) followed women enrolled in 3 large UK studies and estimated the relative risks of breast cancer among women who reported that they worked night shifts versus those who reported that they did not work at night.

The 522,246 women answered questions on shift work and were followed over time. No increase in breast cancer risk associated with night shift work—including long-term night shifts—was found in any of these studies.

In a subsequent meta-analysis, the researchers combined results from the 3 UK studies with those from all 7 previously published prospective studies (2 in the US, 2 in China, 2 in Sweden, and 1 in the Netherlands). The 10 studies included 1.4 million women among whom 4660 breast cancers occurred in women who reported ever having done night shift work. The meta-analysis confirmed that women who worked night shifts were not more likely to develop breast cancer.

The study findings are available here.

Travis RC, Balkwill A, Fensom GA, et al. Night shift work and breast cancer incidence: three prospective studies and meta-analysis of published studies [published online October 6, 2016]. J Natl Cancer Inst.

Related Videos
Pattie Jakel
Christine Wylie
Grace Choong
Ahulwalia on Targeting the Blood Brain Barrier With Novel Immunotherapies and Precision Oncology
Expert in oncology
Expert in oncology
Experts in oncology
Expert in oncology
Related Content
© 2024 MJH Life Sciences

All rights reserved.